Home » Topics » BioWorld Science

BioWorld Science
RSS

OR6A2 is a therapeutic target for atherosclerosis, researchers unveil

Feb. 1, 2022

IDE-161 enters IND-enabling studies

Jan. 31, 2022

Improved retinal transplants ready for clinical trials

Jan. 31, 2022

Design of a next-generation cell-based therapy against diabetes

Jan. 31, 2022

ATH-434 demonstrates efficacy in preclinical multiple system atrophy

Jan. 31, 2022

STI-1558 strongly inhibits Omicron variant in cell-based assays

Jan. 31, 2022

New antipsychotic shows partial agonist activity at DRD2/3 and 5-HT1AR with little 5-HT2AR binding

Jan. 31, 2022

Chengdu Fanxi Biopharma identifies PPAR-alpha and/or PPAR-delta agonists

Jan. 31, 2022

Shanghai Institute of Materia Medica patents glucose-lowering agents

Jan. 31, 2022

New IL-17RA antagonists presented by Hitgen

Jan. 31, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...